NCT03007394 - Lorcaserin in the Treatment of Cocaine Use Disorder | Biotech Hunter

Enrollment

272

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions

Cocaine-Related Disorders

Interventions

DRUG

Lorcaserin

Lorcaserin Capsule

DRUG

Placebo Oral Capsule

sugar pill to mimic lorcaserin 10mg capsule

Trial Locations (12)

George Washington University, Washington D.C.

Behavioral Clinical Research, Inc., North Miami

Meridien Research, Lakeland

Neuro-Behavioral Clinical Research Inc., Canton

University of Cincinnati, Cincinnati

Altea Research Institute, Las Vegas

Matrix Institute on Addictions, Los Angeles

Pacific Treatment and Research Center, La Jolla

CODA, Inc., Portland

Pharmacology Research Institute, Newport Beach

Boston University School of Medicine, Boston

Hassman Research Institute, Berlin

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH